Ann: Quarterly Report - September 2015, page-3

Was pleased with the wording on the Medivet 'impending' dilution of the  medivet business too.

"As the divestment/dilution of its interest in the MediVet business is impending, as noted above, MLA will now strengthen its focus on the growth of its Human Healthcare business through further product development, geographic expansion - in particular South East Asia, organic growth and value accretive acquisitions."

As I mentioned a week or so ago, Bruce Hancox's M&A background could likely to be tested with some of the MediVet proceeds. Would be interesting to see what might be lined up in that space.

DYOR, IMO etc....